Agonist | Ca2+ Release (n = 6) | cAMP (n = 5) | ECAR (n = 4) | logTRn [pathway 1-pathway 2] | |||||
---|---|---|---|---|---|---|---|---|---|
[cAMP-Ca2+] (Bias Factor) | [ECAR-cAMP] (Bias Factor) | [ECAR-Ca2+] (Bias Factor) | |||||||
logTR | logTRn | logTR | logTRn | logTR | logTRn | ||||
Norepinephrine | 8.46 ± 0.14 | 0.00 ± 0.19 | 5.48 ± 0.11 | 0.00 ± 0.16 | 7.48 ± 0.11 | 0.00 ± 0.18 | 0.00 ± 0.25 (1.0) | 0.00 ± 0.24 (1.0) | 0.00 ± 0.26 (1.0) |
Methoxamine | 7.24 ± 0.14 | −1.22 ± 0.20 | 4.27 ± 0.13 | −1.21 ± 0.18 | 6.87 ± 0.11 | −0.61 ± 0.18 | 0.01 ± 0.26 (1.0) | 0.60 ± 0.25* (4.0) | 0.61 ± 0.26 (4.0) |
Phenylephrine | 7.94 ± 0.14 | −0.52 ± 0.20 | 4.76 ± 0.14 | −0.72 ± 0.18 | 8.27 ± 0.12 | 0.79 ± 0.18 | −0.20 ± 0.27 (0.63) | 1.52 ± 0.26*** (33) | 1.31 ± 0.27** (21) |
Oxymetazoline | 8.52 ± 0.15 | 0.06 ± 0.21 | N.A. | N.A. | 8.46 ± 0.12 | 0.98 ± 0.19 | N.A. | N.A. | 0.91 ± 0.28* (8.2) |
Cirazoline | 8.57 ± 0.14 | 0.11 ± 0.20 | 6.46 ± 0.22 | 0.98 ± 0.25 | 8.10 ± 0.11 | 0.62 ± 0.18 | 0.87 ± 0.32* (7.4) | −0.36 ± 0.31 (0.44) | 0.51 ± 0.27 (3.2) |
A61603 | 9.58 ± 0.15 | 1.12 ± 0.20 | 7.54 ± 0.12 | 2.06 ± 0.16 | 9.03 ± 0.11 | 1.55 ± 0.19 | 0.94 ± 0.26** (8.6) | −0.51 ± 0.25 (0.31) | 0.43 ± 0.28 (2.7) |